Standout Papers

Efficacy and Safety of Alirocumab in ... 1998 2026 2007 2016 1.6k
  1. Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events (2015)
    Jennifer G. Robinson, Michel Farnier et al. New England Journal of Medicine
  2. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (2015)
    F. Xavier Pi‐Sunyer, Arne Astrup et al. New England Journal of Medicine
  3. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients (1998)
    Lars Sjöström, Aila Rissanen et al. The Lancet
  4. ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia (2015)
    John J.P. Kastelein, Henry N. Ginsberg et al. European Heart Journal

Immediate Impact

1 by Nobel laureates 4 from Science/Nature 64 standout
Sub-graph 1 of 20

Citing Papers

Tirzepatide for Obesity Treatment and Diabetes Prevention
2024 Standout
Obesity in adults
2024 Standout

Works of Michel Krempf being referenced

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
2015 Standout

Author Peers

Author Last Decade Papers Cites
Michel Krempf 5304 3576 2056 265 10.7k
Dimitri P. Mikhailidis 5995 3332 1795 416 14.3k
Russell Scott 4665 5727 2616 237 11.1k
Bertrand Cariou 6208 4733 4062 303 12.9k
Esko A. Nikkilä 4268 7125 1949 189 12.7k
John R. Guyton 6098 3227 1695 164 11.7k
D. J. Betteridge 3442 4158 1552 141 9.6k
Željko Reiner 6586 3570 1456 257 12.8k
G. Kees Hovingh 7161 3865 1747 203 11.2k
Vasilios G. Athyros 3843 4026 1248 273 10.2k
John J. Albers 7953 6578 2703 198 14.7k

All Works

Loading papers...

Rankless by CCL
2026